CRWV insider sale notice — 281,250 shares via Morgan Stanley, NASDAQ
Rhea-AI Filing Summary
CoreWeave, Inc. (CRWV) Form 144 filing discloses a proposed sale of 281,250 shares of Common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $26,125,312.50. The shares were acquired as Founders Shares from the issuer on 12/27/2023 and payment was recorded on the same date. The filing lists 370,470,348 shares outstanding and indicates the approximate date of sale as 08/20/2025. No securities were reported sold in the prior three months, and the filer affirms they do not possess undisclosed material adverse information.
Positive
- Required disclosure provided under Rule 144 detailing broker, quantity, acquisition date, and aggregate market value
- Filer attests they do not possess undisclosed material adverse information, which is a regulatory safeguard
Negative
- Insider intends to sell founder shares, which could increase available float when executed
- Filing does not identify the selling person (name not provided in the excerpt), limiting investor ability to assess context
Insights
TL;DR: An insider filing to sell founder shares via Morgan Stanley for $26.1M on NASDAQ; routine disclosure, watch timing.
The filing documents a proposed sale of 281,250 common shares acquired as founders shares on 12/27/2023. The broker is Morgan Stanley Smith Barney LLC and the sale is slated for 08/20/2025. The filer affirms no undisclosed material adverse information. This is a standard Rule 144 notice enabling a restricted/controlled holder to publicly disclose an intended sale; it does not itself confirm execution or motive. For investors, the notice increases transparency about potential share supply but contains no new operational or financial performance data.
TL;DR: Governance disclosure completed for proposed founder-share sale; signature attestations included, no compliance exceptions noted.
The form includes required attestations regarding material information and references Rule 10b5-1 considerations. It lists broker details and acquisition history (founders shares from issuer dated 12/27/2023). There are no reported securities sales in the past three months. The filing meets procedural requirements for controlled/insider dispositions under Rule 144 but does not provide identities or any trading plan text. From a governance perspective, the document fulfills notice obligations without revealing nonpublic operational matters.
AI-generated analysis. How Rhea-AI works. Not financial advice.